Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Su, Bo ^a   Liu, Haihua ^a   Wang, Xinglong ^a   Chen, Shu G ^a   Siedlak, Sandra L ^a   Kondo, Eisaku ^b   Choi, Raymond ^a   Takeda, Atsushi ^c   Castellani, Rudy J ^d   Perry, George ^e   Smith, Mark A ^a   Zhu, Xiongwei ^a   Lee, Hyoung Gon ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN 14 3 3; TRANSCRIPTION FACTOR FKHRL1;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 69049098199     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-32     Document Type: Article

References (44)

1. Protein stability and aggregation in Parkinson's disease. PA Robinson, Biochem J 2008 413 1 13 10.1042/BJ20080295 18537793
2. Alpha-synuclein dysfunction in Lewy body diseases. GK Tofaris MG Spillantini, Mov Disord 2005 20 Suppl 12 S37 44 10.1002/mds.20538 16092089
3. Protein aggregation and neurodegenerative disease. CA Ross MA Poirier, Nat Med 2004 10 Suppl S10 17 10.1038/nm1066 15272267
4. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. MG Spillantini M Goedert, Ann N Y Acad Sci 2000 920 16 27 11193145
5. Staging of brain pathology related to sporadic Parkinson's disease. H Braak K Del Tredici U Rub RA de Vos EN Jansen Steur E Braak, Neurobiol Aging 2003 24 197 211 10.1016/S0197-4580(02)00065-9 12498954
6. Alpha-synuclein in Lewy bodies. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert, Nature 1997 388 839 840 10.1038/42166 9278044
7. Lewy bodies. CW Shults, Proc Natl Acad Sci USA 2006 103 1661 1668 16449387 10.1073/pnas.0509567103
8. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. Y Kawamoto I Akiguchi S Nakamura Y Honjyo H Shibasaki H Budka, J Neuropathol Exp Neurol 2002 61 245 253 11895039
9. 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. A Ubl D Berg C Holzmann R Kruger K Berger T Arzberger A Bornemann O Riess, Brain Res Mol Brain Res 2002 108 33 39 10.1016/S0169-328X(02)00510-7 12480176
10. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. K Wakabayashi K Tanji F Mori H Takahashi, Neuropathology 2007 27 494 506 10.1111/j.1440-1789.2007. 00803.x 18018486
11. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. P Foley P Riederer, J Neurol 2000 247 Suppl 2 II82 94 10.1007/PL00007766 10991671
12. Sequestration of iron by Lewy bodies in Parkinson's disease. RJ Castellani SL Siedlak G Perry MA Smith, Acta Neuropathol 2000 100 111 114 10.1007/s004010050001 10963356
13. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. K Lin JB Dorman A Rodan C Kenyon, Science 1997 278 1319 1322 10.1126/science.278.5341.1319 9360933
14. Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons. K Fukunaga T Ishigami T Kawano, J Pharmacol Sci 2005 98 205 211 10.1254/jphs.FMJ05001X3 16006742
15. A brief introduction to FOXOlogy. BM Burgering, Oncogene 2008 27 2258 2262 10.1038/onc.2008.29 18391968
16. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. A Brunet A Bonni MJ Zigmond MZ Lin P Juo LS Hu MJ Anderson KC Arden J Blenis ME Greenberg, Cell 1999 96 857 868 10.1016/S0092-8674(00) 80595-4 10102273
17. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Z Tothova R Kollipara BJ Huntly BH Lee DH Castrillon DE Cullen EP McDowell S Lazo-Kallanian IR Williams C Sears SA Armstrong E Passegue RA DePinho DG Gilliland, Cell 2007 128 325 339 10.1016/j.cell.2007.01.003 17254970
18. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease. HG Lee O Ogawa X Zhu MJ O'Neill RB Petersen RJ Castellani H Ghanbari G Perry MA Smith, Acta Neuropathol 2004 107 365 371 10.1007/s00401-004-0820-8 14872255
19. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. MA Smith RK Kutty PL Richey SD Yan D Stern GJ Chader B Wiggert RB Petersen G Perry, Am J Pathol 1994 145 42 47 8030754
20. Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. GS Jin E Kondo T Miyake M Shibata T Takashima YX Liu K Hayashi T Akagi T Yoshino, Acta Med Okayama 2004 58 197 205 15551757
21. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. WP Gai HX Yuan XQ Li JT Power PC Blumbergs PH Jensen, Exp Neurol 2000 166 324 333 10.1006/exnr.2000.7527 11085897
22. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). WR Gibb MM Esiri AJ Lees, Brain 1987 110 Pt 5 1131 1153 10.1093/brain/110.5.1131 2823957
23. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. L Hansen D Salmon D Galasko E Masliah R Katzman R DeTeresa L Thal MM Pay R Hofstetter M Klauber et al., Neurology 1990 40 1 8 2153271
24. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. CF Lippa ML Schmidt VM Lee JQ Trojanowski, Ann Neurol 1999 45 353 357 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0. CO;2-4 10072050
25. FOXOs, cancer and regulation of apoptosis. Z Fu DJ Tindall, Oncogene 2008 27 2312 2319 10.1038/onc.2008.24 18391973
26. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. X Zhu RJ Castellani A Takeda A Nunomura CS Atwood G Perry MA Smith, Mech Ageing Dev 2001 123 39 46 10.1016/S0047-6374(01) 00342-6 11640950
27. Alzheimer's disease: the two-hit hypothesis. X Zhu AK Raina G Perry MA Smith, Lancet Neurol 2004 3 219 226 10.1016/S1474-4422(04)00707-0 15039034
28. Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. C Barthelemy CE Henderson B Pettmann, BMC Neurosci 2004 5 48 15569384 10.1186/1471-2202-5-48
29. Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. D Davila I Torres-Aleman, Mol Biol Cell 2008 19 2014 2025 18287535 10.1091/mbc.E07-08-0811
30. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. M Hashimoto LJ Hsu E Rockenstein T Takenouchi M Mallory E Masliah, J Biol Chem 2002 277 11465 11472 10.1074/jbc.M111428200 11790792
31. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. AB Manning-Bog AL McCormack MG Purisai LM Bolin DA Di Monte, J Neurosci 2003 23 3095 3099 12716914
32. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. T Hasegawa M Matsuzaki A Takeda A Kikuchi H Akita G Perry MA Smith Y Itoyama, Brain Res 2004 1013 51 59 10.1016/j.brainres.2004.04.018 15196967
33. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. M Matsuzaki T Hasegawa A Takeda A Kikuchi K Furukawa Y Kato Y Itoyama, Brain Res 2004 1004 83 90 10.1016/j.brainres.2004.01.017 15033422
34. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. RJ Castellani HG Lee X Zhu A Nunomura G Perry MA Smith, Acta Neuropathol 2006 111 503 509 10.1007/s00401-006-0071-y 16718346
35. Alzheimer disease pathology as a host response. RJ Castellani HG Lee X Zhu G Perry MA Smith, J Neuropathol Exp Neurol 2008 67 523 531 10.1097/NEN.0b013e318177eaf4 18520771
36. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. BI Giasson JE Duda IV Murray Q Chen JM Souza HI Hurtig H Ischiropoulos JQ Trojanowski VM Lee, Science 2000 290 985 989 10.1126/science.290.5493.985 11062131
37. Oxidative stress and neurotoxicity. LM Sayre G Perry MA Smith, Chem Res Toxicol 2008 21 172 188 10.1021/tx700210j 18052107
38. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. RJ Castellani G Perry SL Siedlak A Nunomura S Shimohama J Zhang T Montine LM Sayre MA Smith, Neurosci Lett 2002 319 25 28 10.1016/S0304-3940(01)02514-9 11814645
39. Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease. HG Lee M Ueda Y Miyamoto Y Yoneda G Perry MA Smith X Zhu, Brain Res 2006 1124 1 4 10.1016/j.brainres.2006.09.084 17070506
40. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? HG Lee M Ueda X Zhu G Perry MA Smith, J Neurosci Res 2006 84 1856 1861 10.1002/jnr.21072 16998902
41. Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. W Qin W Zhao L Ho J Wang K Walsh S Gandy GM Pasinetti, Ann N Y Acad Sci 2008 1147 335 347 19076455
42. 14-3-3 proteins: a historic overview. A Aitken, Semin Cancer Biol 2006 16 162 172 10.1016/j.semcancer.2006.03.005 16678438
43. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. RJ Castellani K Honda X Zhu AD Cash A Nunomura G Perry MA Smith, Ageing Res Rev 2004 3 319 326 10.1016/j.arr.2004.01.002 15231239
44. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. N Ostrerova L Petrucelli M Farrer N Mehta P Choi J Hardy B Wolozin, J Neurosci 1999 19 5782 5791 10407019